Biocon Biologics receives EIR from USFDA for two manufacturing facilities in Bengaluru

Biocon Biologics India Ltd., a subsidiary of Biocon Ltd., said on Thursday it has received the Establishment Inspection Report (EIR) from the USFDA (the United States Food and Drug Administration) for the pre-approval inspection at two of its biologics manufacturing facilities in Bengaluru

|Apr 16, 2020, 11:48:54 IST

Bengaluru: Biocon Biologics India Ltd., a subsidiary of Biocon Ltd., said on Thursday it has received the Establishment Inspection Report (EIR) from the USFDA (the United States Food and Drug Administration) for the pre-approval inspection at two of its biologics manufacturing facilities in Bengaluru.[caption id="attachment_4470095" align="alignleft" width="380"]

Biocon. Representational image. Reuters.[/caption]The inspection was conducted between 10 September and 19 September, 2019, a company spokesperson said, adding, Biocon Biologics has responded to the regulator on the eight observations from this inspection, in October last year.Click here to follow LIVE news and updates on stock marketsSubsequently, Biocon Biologics has received approvals for the two products Trastuzumab (Drug Product) and Pegfilgrastim (Drug Substance) from the USFDA in 2019."The receipt of the EIR indicates a successful closure of the inspection," the spokesperson said. "The formal closure of the USFDA inspection is expected to enable filing of marketing authorisation applications for our biosimilar products in several global markets."

Google burns cash for first time as AI spending pushes 2026 capex to $205 billion

Google parent Alphabet reported negative free cash flow of $5.9 billion in the second quarter for the first time since going public, as surging AI infrastructure spending pushed its 2026 capital expenditure forecast to as much as $205 billion

6 min read

Tesla sells more cars but makes less money: Why Musk’s AI pivot is squeezing profits

Tesla’s record Q2 deliveries failed to translate into higher profits as price cuts, falling regulatory-credit revenue and Elon Musk’s aggressive AI spending squeezed margins and pushed the EV maker into negative free cash flow

5 min read

No premium queues, 30-minute target: What changes for Indian passport applicants in UAE

Indian passport applicants in the UAE can now access passport, visa and attestation services through Alhind’s 16 centres, with no premium queues, a Dh19 service fee and a target of completing applications within 30 minutes

4 min read

Bharat Forge, Flying Whales sign pact to develop 60-tonne airships for India’s defence logistics

Bharat Forge has signed an MoU with Flying Whales to jointly develop and manufacture 60-tonne heavy-lift airships in India for defence logistics, strategic mobility and disaster response

3 min read

Air India to cut Delhi-Toronto flight time by 3 hours, resume non-stop services from August 1

Air India will resume non-stop Delhi-Toronto flights from August 1, cutting travel time by nearly three hours and deploying its new Boeing 787-9 Dreamliner on the route

2 min read

Up Next